symbol,title,summary,url,time_published,sentiment_score,source
VRTX,Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,"High-rolling investors have positioned themselves bearish on Vertex Pharmaceuticals VRTX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.",https://www.benzinga.com/insights/options/24/08/40533961/unpacking-the-latest-options-trading-trends-in-vertex-pharmaceuticals,20240823T180509,0.150268,Benzinga
VRTX,Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead,Vertex Pharmaceuticals has a lot going for it.,https://www.fool.com/investing/2024/08/23/forget-novo-nordisk-buy-magnificent-pharma-stock/,20240823T094500,0.219553,Motley Fool
VRTX,"Top Stock Reports for Texas Instruments, Union Pacific & Vertex Pharmaceuticals","Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Incorporated (TXN), Union Pacific Corporation (UNP) and Vertex Pharmaceuticals Incorporated (VRTX), as well as two micro-cap stocks Tile Shop Holdings, Inc. (TTSH) and Gencor Industries, Inc. ...",https://www.zacks.com/research-daily/2325736/top-stock-reports-for-texas-instruments-union-pacific-vertex-pharmaceuticals,20240822T161000,0.084707,Zacks Commentary
VRTX,"If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ","Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 13.22% on an annualized basis producing an average annual return of 21.66%. Currently, Vertex Pharmaceuticals has a market capitalization of $125.87 billion.",https://www.benzinga.com/insights/news/24/08/40490475/if-you-invested-100-in-this-stock-20-years-ago-you-would-have-4-900-today,20240821T163020,0.238974,Benzinga
VRTX,Vertex Pharmaceuticals Incorporated  ( VRTX )  Is a Trending Stock: Facts to Know Before Betting on It,"Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://www.zacks.com/stock/news/2324864/vertex-pharmaceuticals-incorporated-vrtx-is-a-trending-stock-facts-to-know-before-betting-on-it,20240821T130011,0.230589,Zacks Commentary
VRTX,"Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies - Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings - Broadcom  ( NASDAQ:AVGO ) , Airbnb  ( NASDAQ:ABNB ) ","Renaissance Technologies, the hedge fund founded by legendary mathematician and former National Security Agency code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities and Exchange Commission on Aug. 9.",https://www.benzinga.com/markets/equities/24/08/40453485/soviet-code-breaker-jim-simons-hedge-fund-renaissance-technologies-ozempic-wegovy-maker-novo-nor,20240820T022541,0.37625,Benzinga
VRTX,CRISPR  ( CRSP )  Loses 24% YTD: How Should You Play the Stock?,"Despite gaining regulatory approvals in many countries for the first ever CRISPR-based gene therapy, investors should remain wary of investing in CRISPR Therapeutics' (CRSP) early-stage pipeline.",https://www.zacks.com/stock/news/2323980/crispr-crsp-loses-24-ytd-how-should-you-play-the-stock,20240819T154300,0.175834,Zacks Commentary
VRTX,Should You Invest in the VanEck Biotech ETF  ( BBH ) ?,Sector ETF report for ...,https://www.zacks.com/stock/news/2323511/should-you-invest-in-the-vaneck-biotech-etf-bbh,20240819T102006,0.186436,Zacks Commentary
VRTX,These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond,It's always a good time to invest cash in quality businesses.,https://www.fool.com/investing/2024/08/18/these-2-incredible-growth-stocks-are-set-to-soar-t/,20240818T090000,0.256227,Motley Fool
VRTX,3 Fantastic Growth Stocks to Buy in August,These stocks should keep up their winning ways.,https://www.fool.com/investing/2024/08/17/3-fantastic-growth-stocks-to-buy-in-august/,20240817T113000,0.361236,Motley Fool
VRTX,BMY vs. VRTX: Which Stock Is the Better Value Option?,Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb ( BMY Quick QuoteBMY - ) or Vertex Pharmaceuticals ( VRTX Quick QuoteVRTX - ) . But which of these two stocks is more attractive to value investors?,https://www.zacks.com/stock/news/2322713/bmy-vs-vrtx-which-stock-is-the-better-value-option,20240815T154009,0.481956,Zacks Commentary
VRTX,Vertex  ( VRTX )  Stock Outperforms Industry YTD: Here's Why,Vertex's (VRTX) CF sales are expected to remain strong despite a slight slowdown in the growth rate. Casgevy and suzetrigine (if approved) are set to provide the necessary diversification from the CF franchise.,https://www.zacks.com/stock/news/2322412/vertex-vrtx-stock-outperforms-industry-ytd-heres-why,20240815T120200,0.151556,Zacks Commentary
VRTX,Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them,These technologies could be game-changers. And they could make forward-thinking investors a lot of money.,https://www.fool.com/investing/2024/08/15/prediction-these-4-future-technologies-will-be-mil/,20240815T094500,0.348369,Motley Fool
VRTX,2 Biotech Stocks To Watch In August 2024,"The biotech sector focuses on developing innovative medical treatments using biological processes. These companies research and create new drugs, therapies, and medical devices. Biotech stocks represent ownership in these cutting-edge firms.",https://stockmarket.com/featured/2-biotech-stocks-to-watch-in-august-2024-2024-08-13,20240814T003656,0.101828,StockMarket.com
VRTX,2 Biotech Stocks to Buy Hand Over Fist in August,Both of these biotechs are highly innovative companies.,https://www.fool.com/investing/2024/08/12/2-biotech-stocks-to-buy-hand-over-fist-in-august/,20240812T133000,0.225813,Motley Fool
VRTX,Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ,"Investors with significant funds have taken a bearish position in Vertex Pharmaceuticals VRTX, a development that retail traders should be aware of. This was brought to our attention today through our monitoring of publicly accessible options data at Benzinga.",https://www.benzinga.com/insights/options/24/08/40293136/unpacking-the-latest-options-trading-trends-in-vertex-pharmaceuticals,20240809T184555,0.05269,Benzinga
VRTX,ProKidney Reports Business Updates and Second Quarter 2024 Financial Results,"WINSTON-SALEM, N.C., Aug. 09, 2024 ( GLOBE NEWSWIRE ) -- ProKidney Corp. ( Nasdaq: PROK ) ( ""ProKidney"" or the ""Company"" ) , a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease ( CKD ) , today reported business updates and financial results for the ...",https://www.globenewswire.com/news-release/2024/08/09/2927692/0/en/ProKidney-Reports-Business-Updates-and-Second-Quarter-2024-Financial-Results.html,20240809T110000,0.116102,GlobeNewswire
VRTX,The Zacks Analyst Blog Vertex Pharmaceuticals CRISPR and Moderna,Vertex Pharmaceuticals CRISPR and Moderna are included in this Analyst Blog.,https://www.zacks.com/stock/news/2319736/the-zacks-analyst-blog-vertex-pharmaceuticals-crispr-and-moderna,20240809T083000,0.135687,Zacks Commentary
VRTX,"Cathie Wood's Ark Invest Continues Loads Up On $6.05M Worth Of Robinhood Shares Amid Bitcoin Rebound, Dumps Zoom Stock - Robinhood Markets  ( NASDAQ:HOOD ) ","On Thursday, Cathie Wood-led Ark Invest made some significant trades, notably buying Robinhood Markets Inc HOOD and selling Zoom Video Communications Inc ZM. Ark Invest's decision to purchase Robinhood shares comes in the wake of the trading platform's impressive second-quarter revenue beat.",https://www.benzinga.com/markets/cryptocurrency/24/08/40274766/cathie-woods-ark-invest-continues-loads-up-on-6-05m-worth-of-robinhood-shares-amid-bitcoin,20240809T023910,0.310395,Benzinga
VRTX,"Top Research Reports for NVIDIA, Home Depot & Vertex Pharmaceuticals","Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), The Home Depot, Inc. (HD) and Vertex Pharmaceuticals Incorporated (VRTX), as well as a micro-cap stock Moving iMage Technologies, Inc. (MITQ).",https://www.zacks.com/research-daily/2318933/top-research-reports-for-nvidia-home-depot-vertex-pharmaceuticals,20240808T204900,0.259078,Zacks Commentary
VRTX,"Editas Q2 Earnings & Revenues Miss Estimates, Stock Down - Annovis Bio  ( NYSE:ANVS ) , Akero Therapeutics  ( NASDAQ:AKRO ) ","Editas Medicine, Inc. EDIT incurred a loss of 82 cents per share in the second quarter of 2024, wider than the Zacks Consensus Estimate of a loss of 69 cents. The company had reported a loss of 56 cents per share in the year-ago quarter.",https://www.benzinga.com/general/biotech/24/08/40256886/editas-q2-earnings-revenues-miss-estimates-stock-down,20240808T195906,0.064568,Benzinga
VRTX,"Here's How to Play Vertex  ( VRTX )  Stock After Q2 Loss, Price Dip",Vertex (VRTX) is a great stock to have in one's portfolio based on its strong overall financial performance and robust pipeline progress.,https://www.zacks.com/stock/news/2319355/heres-how-to-play-vertex-vrtx-stock-after-q2-loss-price-dip,20240808T150700,0.128847,Zacks Commentary
VRTX,"Editas  ( EDIT )  Q2 Earnings & Revenues Miss Estimates, Stock Down",Editas (EDIT) reports lower-than-expected second-quarter 2024 results as both earnings and revenues miss estimates. The stock falls 12.2%.,https://www.zacks.com/stock/news/2319312/editas-edit-q2-earnings-revenues-miss-estimates-stock-down,20240808T133300,0.047761,Zacks Commentary
VRTX,Is iShares Biotechnology ETF  ( IBB )  a Strong ETF Right Now?,Smart Beta ETF report for ...,https://www.zacks.com/stock/news/2317659/is-ishares-biotechnology-etf-ibb-a-strong-etf-right-now,20240807T102006,0.254443,Zacks Commentary
VRTX,CRISPR Therapeutics  ( CRSP )  Q2 Loss Wider Than Expected,"CRISPR Therapeutics (CRSP) incurs a wider-than-expected loss in the second quarter of 2024. The commercial launch of CRISPR-based gene therapy, Casgevy, is progressing well.",https://www.zacks.com/stock/news/2317138/crispr-therapeutics-crsp-q2-loss-wider-than-expected,20240806T143700,0.106816,Zacks Commentary
VRTX,Investors Heavily Search Vertex Pharmaceuticals Incorporated  ( VRTX ) : Here is What You Need to Know,"Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.",https://www.zacks.com/stock/news/2316816/investors-heavily-search-vertex-pharmaceuticals-incorporated-vrtx-here-is-what-you-need-to-know,20240806T130012,0.254708,Zacks Commentary
VRTX,Is It Too Late to Buy Vertex Pharmaceuticals Stock?,Shares of the rare disease drugmaker are already up more than 40% over the past year.,https://www.fool.com/investing/2024/08/06/is-it-too-late-to-buy-vertex-pharmaceuticals-stock/,20240806T083100,0.151829,Motley Fool
VRTX,Prediction: These Could Be the Best-Performing Growth Stocks Through 2030,Great companies are found in every type of market landscape.,https://www.fool.com/investing/2024/08/05/prediction-these-could-be-the-best-performing-grow/,20240805T105500,0.291371,Motley Fool
VRTX,Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker,The biotech recently became a commercial-stage company.,https://www.fool.com/investing/2024/08/04/prediction-crispr-therapeutics-stock-could-be-a-mi/,20240804T102200,0.258458,Motley Fool
VRTX,3 Unstoppable Stocks to Buy in August,It's not hard to envision how all three of these stocks can deliver exceptional growth.,https://www.fool.com/investing/2024/08/03/3-unstoppable-stocks-to-buy-in-august/,20240803T114500,0.166551,Motley Fool
VRTX,Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now,These two healthcare companies have far more upside potential than Johnson & Johnson.,https://www.fool.com/investing/2024/08/03/prediction-2-stocks-that-will-be-worth-more-than-j/,20240803T103800,0.231837,Motley Fool
VRTX,Vertex Raises Guidance Despite Q2's Bottom-Line Losses,"Revenues rose, but the drugmaker experienced a significant net income loss due to acquisition expenses.",https://www.fool.com/data-news/2024/08/02/vertex-raises-guidance-despite-q2-s-bottom-line-losses/,20240802T184843,0.201699,Motley Fool
VRTX,"Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline - Vertex Pharmaceuticals  ( NASDAQ:VRTX ) ","Thursday, Vertex Pharmaceuticals Incorporated VTRX reported second-quarter revenues of $2.65 billion, almost in line with the consensus of estimate of $2.66 billion. Vertex Pharmaceuticals reported an adjusted EPS loss of $ ( 12.83 ) , compared to $3.89 a year ago, missing the consensus of $4.14.",https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40138336/vertex-pharmaceuticals-lifts-annual-guidance-positive-growth-for-its-cystic-fibrosi,20240802T174819,0.216735,Benzinga
VRTX,"Vertex  ( VRTX )  Q2 Loss Wider Than Expected, '24 Sales View Raised",Vertex (VRTX) incurs a wider-than-expected loss in the second quarter while sales come in line with estimates. Vertex raises its full-year product revenue guidance.,https://www.zacks.com/stock/news/2315322/vertex-vrtx-q2-loss-wider-than-expected-24-sales-view-raised,20240802T140300,0.090358,Zacks Commentary
VRTX,Should You Invest in Vertex  ( VRTX )  Based on Bullish Wall Street Views?,"According to the average brokerage recommendation (ABR), one should invest in Vertex (VRTX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?",https://www.zacks.com/stock/news/2315166/should-you-invest-in-vertex-vrtx-based-on-bullish-wall-street-views,20240802T133012,0.278346,Zacks Commentary
VRTX,Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.,Vertex's first loss in years is a big nothingburger.,https://www.fool.com/investing/2024/08/02/should-investors-worry-about-vertex-pharmaceutical/,20240802T095000,0.144306,Motley Fool
VRTX,Vertex Pharmaceuticals  ( VRTX )  Q2 2024 Earnings Call Transcript,"VRTX earnings call for the period ending June 30, 2024.",https://www.fool.com/earnings/call-transcripts/2024/08/01/vertex-pharmaceuticals-vrtx-q2-2024-earnings-call/,20240802T013018,0.20845,Motley Fool
VRTX,"Vertex Pharmaceuticals  ( VRTX )  Reports Q2 Loss, Misses Revenue Estimates","Vertex (VRTX) delivered earnings and revenue surprises of -11.57% and 0.08%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?",https://www.zacks.com/stock/news/2314628/vertex-pharmaceuticals-vrtx-reports-q2-loss-misses-revenue-estimates,20240801T211511,0.146317,Zacks Commentary
VRTX,"Moderna  ( MRNA )  Q2 Earnings Beat, Stock Down on Guidance Slash",Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.,https://www.zacks.com/stock/news/2314559/moderna-mrna-q2-earnings-beat-stock-down-on-guidance-slash,20240801T155400,0.021531,Zacks Commentary
VRTX,Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever,These businesses are looking like increasingly attractive buys.,https://www.fool.com/investing/2024/08/01/got-500-2-compelling-growth-stocks-to-buy-and-hold/,20240801T141500,0.20625,Motley Fool
VRTX,"Wall Street Poised To Start Higher: What's Driving Action In Futures Market - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ","After Wednesday's tech-led rebound amid the Federal Reserve's rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a slowdown in the upward momentum is in the cards.",https://www.benzinga.com/news/earnings/24/08/40096676/wall-street-looks-to-ride-on-earnings-cheer-as-meta-q2-impresses-investors-analyst-says-economic-da,20240801T113552,0.06455,Benzinga
VRTX,"Should You Invest in the iShares Biotechnology ETF? - First Trust Amex Biotech Index Fund  ( ARCA:FBT ) , Amgen  ( NASDAQ:AMGN ) ","Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF IBB is a passively managed exchange traded fund launched on 02/05/2001.",https://www.benzinga.com/general/biotech/24/07/40064786/should-you-invest-in-the-ishares-biotechnology-etf,20240731T174834,0.264116,Benzinga
VRTX,Should You Invest in the iShares Biotechnology ETF  ( IBB ) ?,Sector ETF report for ...,https://www.zacks.com/stock/news/2312595/should-you-invest-in-the-ishares-biotechnology-etf-ibb,20240731T102007,0.236543,Zacks Commentary
VRTX,Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?,"Let's focus on biotech stocks like GSK, VRTX, BIIB, MRNA and REGN, which are scheduled to report this week.",https://www.zacks.com/stock/news/2312313/watch-these-5-biotech-stocks-for-q2-earnings-beat-or-miss,20240730T173100,0.148346,Zacks Commentary
VRTX,BMY vs. VRTX: Which Stock Should Value Investors Buy Now?,BMY vs. VRTX: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/2312160/bmy-vs-vrtx-which-stock-should-value-investors-buy-now,20240730T154011,0.476284,Zacks Commentary
VRTX,DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?,"DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now.",https://www.fool.com/investing/2024/07/30/dexcom-stock-plunged-eli-lilly-novo-nordisk/,20240730T094800,0.009701,Motley Fool
VRTX,"Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics","Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics have been highlighted in this Industry Outlook article.",https://www.zacks.com/stock/news/2311476/zacks-industry-outlook-highlights-moderna-sarepta-therapeutics-halozyme-therapeutics-krystal-biotech-and-axsome-therapeutics,20240730T090600,0.247578,Zacks Commentary
VRTX,Vertex  ( VRTX )  Stock Before Q2 Earnings: To Buy or Not to Buy?,"Vertex's (VRTX) second-quarter revenues are expected to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.",https://www.zacks.com/stock/news/2311058/vertex-vrtx-stock-before-q2-earnings-to-buy-or-not-to-buy,20240729T144400,0.246688,Zacks Commentary
VRTX,5 Biotech Stocks to Bet On Bright Industry Prospects,"New drug approvals and strong pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position MRNA, SRPT, HALO, KRYS and AXSM well in this volatile sector.",https://www.zacks.com/commentary/2310685/5-biotech-stocks-to-bet-on-bright-industry-prospects,20240729T134100,0.23638,Zacks Commentary
VRTX,Curious about Vertex  ( VRTX )  Q2 Performance? Explore Wall Street Estimates for Key Metrics,"Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Vertex (VRTX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.",https://www.zacks.com/stock/news/2310694/curious-about-vertex-vrtx-q2-performance-explore-wall-street-estimates-for-key-metrics,20240729T131613,0.190807,Zacks Commentary
